MPZAF(MPZAF)
MPZAF
No analyst ratings available
No analyst price targets available for MPZAF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $830M | $1.08B | $1.33B | $1.76B | $1.69B |
| Low | $769M | $933M | $1.24B | $1.63B | $1.56B |
| High | $873M | $1.18B | $1.40B | $1.85B | $1.77B |
| EBITDA Avg | $336M | $436M | $540M | $711M | $683M |
| Low | $311M | $378M | $500M | $658M | $632M |
| High | $353M | $477M | $568M | $748M | $718M |
| EBIT Avg | $309M | $401M | $496M | $653M | $628M |
| Low | $286M | $347M | $460M | $605M | $581M |
| High | $325M | $439M | $522M | $687M | $660M |
| Net Income Avg | $252M | $370M | $489M | $666M | $688M |
| Low | $228M | $334M | $442M | $602M | $622M |
| High | $269M | $395M | $522M | $711M | $734M |
| EPS Avg | $9.52 | $13.96 | $18.44 | $25.13 | $25.97 |
| Low | $8.60 | $12.62 | $16.67 | $22.72 | $23.47 |
| High | $10.16 | $14.90 | $19.69 | $26.83 | $27.72 |
| Analysts (Rev / EPS) | 1 / 1 | 5 / 1 | 1 / 1 | 2 / 1 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $216M | $234M | $177M |
| Low | $196M | $220M | $163M |
| High | $230M | $241M | $185M |
| EBITDA Avg | $87M | $95M | $71M |
| Low | $79M | $89M | $66M |
| High | $93M | $97M | $75M |
| EBIT Avg | $80M | $87M | $66M |
| Low | $73M | $82M | $61M |
| High | $85M | $90M | $69M |
| Net Income Avg | $57M | $83M | $45M |
| Low | $51M | $75M | $41M |
| High | $60M | $88M | $48M |
| EPS Avg | $2.15 | $3.15 | $1.70 |
| Low | $1.94 | $2.84 | $1.53 |
| High | $2.28 | $3.34 | $1.80 |
| Analysts (Rev / EPS) | 4 / 1 | 4 / 1 | 2 / 1 |